|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
5R01CA174432-06
|
$660,173
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
MOTILITY AND INVASION
|
5P01CA100324-16
|
$2,028,990
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048349-26
|
$68,181
|
CRANDALL, JILL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
|
5R01CA178394-05
|
$346,525
|
GAVATHIOTIS, EVRIPIDIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
PI3K Isoform Dependence in Adult Hematopoiesis and Myeloid Leukemia
|
5R01CA196973-03
|
$415,736
|
GRITSMAN, KIRA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
|
1R01CA226861-01
|
$382,013
|
MACIAN, FERNANDO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Young Investigator travel support for the 2016 through 2020 APS Annual Scientific Meetings
|
5R13AT009161-03
|
$5,000
|
PRICE, THEODORE
|
AMERICAN PAIN SOCIETY
|
|
Genetic Analysis of Myeloproliferative Disease
|
5R01CA076167-15
|
$307,800
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
|
5R01CA168912-05
|
$320,588
|
HE, YUKAI
|
AUGUSTA UNIVERSITY
|
|
Proteogenomic Translational Research Center for Clinical Proteomic
|
5U01CA214116-02
|
$1,372,508
|
RODLAND, KARIN
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
A novel N-Ras pathway driving DCIS to basal-like breast cancer
|
1R21CA226567-01
|
$212,055
|
CHANG, ERIC
|
BAYLOR COLLEGE OF MEDICINE
|
|
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
|
5U01CA214125-02
|
$1,413,657
|
ELLIS, MATTHEW
|
BAYLOR COLLEGE OF MEDICINE
|
|
The ATM/E2F1 Pathway in DNA Damage and Growth Control
|
5R01CA100857-14
|
$356,625
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
MOLECULAR DISSECTION OF SEIZURE MICROENVIRONMENT IN MALIGNANT GLIOMA
|
1R01CA223388-01
|
$632,130
|
NOEBELS, JEFFREY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Racial Disparity in Bladder Cancer and Identification of Altered Metabolism in African American Compare to European Bladder Cancer
|
5R01CA220297-02
|
$365,246
|
PUTLURI, NAGIREDDY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Wnt pathway dynamics in breast cancer metastasis
|
5K22CA207463-02
|
$188,042
|
ROARTY, KEVIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Engineering Antibody Drug Conjugates To Target P53-Defective Triple Negative Breast Cancer
|
5R21CA213535-02
|
$207,797
|
WANG, JIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer
|
5R01CA184792-04
|
$347,517
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma
|
5R01CA212119-02
|
$580,951
|
CHEN, YUAN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Epigenomic Biomarkers to Manage Thyroid Nodule Overdiagnosis and Overtreatment
|
1R21CA223367-01
|
$242,633
|
HAHN, MARIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
|
5R01CA213131-02
|
$430,377
|
KORTYLEWSKI, MARCIN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
|
5R01CA213138-02
|
$395,738
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Metabolic basis of B cell lineage leukemia relapse
|
5R35CA197628-03
|
$1,035,561
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting the ARHGAP25 pathway in acute myelogenous leukemia stem cells
|
5K08CA201591-02
|
$169,560
|
WANG, LEO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the Warburg effect
|
5R01CA212605-02
|
$517,798
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Complex Role of HSF1 in Breast Cancer
|
5R01CA176326-05
|
$355,719
|
CALDERWOOD, STUART
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument
|
1R01CA218382-01A1
|
$668,549
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Discussions of Prognosis and Stopping Cancer Screening in Older Adults
|
5R21CA212386-02
|
$189,709
|
SCHONBERG, MARA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
ANTAGONISM OF VEGA-DRIVEN ANGIOGENESIS
|
5R01CA077357-09
|
$303,039
|
SENGER, DONALD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Generation of Antiangiogenic Activity for Cancer Treat.
|
5R01CA098948-05
|
$270,081
|
SUKHATME, VIKAS
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Novel Uses of PI3K-inhibitors for the Treatment of advanced PIK3CA-mutant Breast Cancer
|
1R01CA226776-01
|
$400,313
|
WULF, GERBURG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood
|
5R44CA213595-02
|
$712,071
|
MULLER, ROLF
|
BIOFLUIDICA, INC
|
|
Long Acting VEGF BInding Proteins for Treating Cancer
|
5R44CA099217-03
|
$335,148
|
Cox, George
|
BOLDER BIOTECHNOLOGY, INC.
|
|
Role of Insulin Receptor Substrates in Kras-driven lung cancer
|
5R01CA211944-02
|
$404,888
|
KALAANY, NADA
|
BOSTON CHILDREN'S HOSPITAL
|
|
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE
|
1R01CA227433-01
|
$608,862
|
GRINSTAFF, MARK
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Mammographic density and breast cancer risk in African American women
|
5R01CA214542-02
|
$513,677
|
BERTRAND, KIMBERLY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Improving Accuracy and Reliability in Cancer Screening Tests
|
1R01CA226805-01
|
$313,533
|
NELSON, KERRIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Co-targeting mTOR and YAP signaling in glioblastoma
|
1R01CA217820-01A1
|
$320,490
|
GERA, JOSEPH
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Role of Tim-3 in determining T cell immunity
|
5R01CA187975-04
|
$377,666
|
ANDERSON, ANA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-17
|
$1,666,176
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
|
5R01CA195532-04
|
$377,464
|
CHIOCCA, E
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Chemical Approaches to Cell Signaling Enzymes
|
5R01CA074305-24
|
$340,100
|
COLE, PHILIP
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mucins and immune cell interactions in ovarian cancer pathogenesis & progression
|
5R35CA197605-03
|
$966,086
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Physicians' Health Study II: Prevention Trial of Vitamins
|
2R01CA097193-06A1
|
$1,550,473
|
GAZIANO, J
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Selenoproteins as targets for cancer prevention
|
5R01CA080946-18
|
$223,000
|
GLADYSHEV, VADIM
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Clinical Evaluation of an Implantable Lab-in-a-patient microdevice that measures in-situ response to therapies in advanced ovarian cancer
|
1R21CA216796-01A1
|
$183,736
|
JONAS, OLIVER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-19
|
$228,408
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer
|
1R37CA227190-01
|
$600,105
|
PENNEY, KATHRYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Effects of Vitamin D on Mammographic Density and Breast Tissue
|
5R01CA178263-05
|
$512,511
|
REXRODE, KATHRYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Analysis of T-cell antigen diversity by deep sequencing
|
1R21CA226321-01
|
$107,091
|
HOLT, ROBERT
|
BRITISH COLUMBIA CANCER AGENCY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|